Drug Detail:Gohibic (Vilobelimab [ vil-oh-bel-i-mab ])
Generic Name: vilobelimab 10mg in 1mL
Dosage Form: injection
Drug Class: Miscellaneous antivirals
Drug Detail:Gohibic (Vilobelimab [ vil-oh-bel-i-mab ])
Generic Name: vilobelimab 10mg in 1mL
Dosage Form: injection
Drug Class: Miscellaneous antivirals
The recommended dosage of GOHIBIC for the treatment of adults with COVID-19 is 800 mg administered by intravenous infusion after dilution [see Dosage and Administration (2.2)] for a maximum of 6 (six) doses over the treatment period as described below.
Treatment should be started within 48 hours of intubation (Day 1) followed by administration on Days 2, 4, 8, 15 and 22 as long as the patient is hospitalized (even if discharged from ICU).
Preparation
Using aseptic technique, dilute and prepare GOHIBIC for intravenous infusion before administration.
Storage of Diluted GOHIBIC
Administration